logo-loader
BAE Systems

BAE Systems and Qatar sign around £5bn contract for the supply of Typhoon fighter aircraft

The contract provides for 24 Typhoon aircraft with delivery expected to commence in late 2022

Typhoon fighter jet
BAE is the prime contractor for both the provision of the aircraft and the agreed arrangements for the in-service support and initial training

BAE Systems PLC (LON:BA.) and the Government of the State of Qatar have entered into a contract, valued at approximately £5bn, for the supply of Typhoon aircraft to the Qatar Emiri Air Force along with a bespoke support and training package.

The contract provides for 24 Typhoon aircraft with delivery expected to commence in late 2022.

READ: BAE Systems' shares soar as UK pension funds top-up proves less then expected

BAE is the prime contractor for both the provision of the aircraft and the agreed arrangements for the in-service support and initial training.

Charles Woodburn, BAE Systems’ chief executive said "We are delighted to begin a new chapter in the development of a long-term relationship with the State of Qatar and the Qatar Armed Forces, and we look forward to working alongside our customer as they continue to develop their military capability".

READ: BAE heads lower as it announces plans to cut almost 2,000 jobs

At a ceremony in Doha, UK defence minister, Gavin Williamson and Qatari minister of state for defence Affairs, Khalid bin Mohammed al Attiyah, oversaw the signing of a deal which the British minister called a "massive vote of confidence, supporting thousands of British jobs and injecting billions into our economy".

Quick facts: BAE Systems

Price: £0.00

Market: LSE
Market Cap: £0.00
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Open Orphan 'driving research for novel drug development for rare diseases'

Proactive London sits down with Open Orphan PLC's (LON:ORPH) chief operating officer Maurice Treacy. Treacy discusses how he became involved with Open Orphan and his ambitions for the firm's health data initiative. ''Many rare diseases aren't known or badly diagnosed ... but rare isn't...

7 hours, 57 minutes ago

2 min read